Showing results (221-230 of 320) with videos related to
Sort By:
Pageof 32
Nutrition & Metabolism|March 12, 2025
Vegan diet, processed foods, and body weight: a secondary analysis of a randomized clinical trialHana Kahleova, Tatiana Znayenko-Miller, Arathi Jayaraman, et al.Nature|November 21, 1998
The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338A J King, H Sun, B Diaz, et al.Menopause (New York, N.Y.)|June 25, 2026
Processed foods in the context of a vegan diet, and changes in body weight and severe hot flashes in postmenopausal women: a secondary analysis of a randomized clinical trialHana Kahleova, Tatiana Znayenko-Miller, Arathi Jayaraman, et al.Diabetes Spectrum : a Publication of the American Diabetes Association|June 21, 2021
Injection Technique: Development of a Novel Questionnaire and User GuideKatharine D Barnard-Kelly, Edward Mahoney, Leah Baccari, et al.Frontiers in Nutrition|December 5, 2025
Plant-based dietary index on the Mediterranean and a vegan diet: a secondary analysis of a randomized, cross-over trialHana Kahleova, Reagan Smith, Ilana Fischer, et al.BMC Nutrition|October 15, 2025
Can a vegan diet help people with type 1 diabetes save on insulin? A secondary analysis of a 12-Week randomized clinical trialHana Kahleova, Cristina Maracine, Tatiana Znayenko-Miller, et al.Diabetic Medicine : a Journal of the British Diabetic Association|December 5, 2014
Challenges of optimizing glycaemic control in children with Type 1 diabetes: a qualitative study of parents' experiences and viewsJ Lawton, N Waugh, K D Barnard, et al.JAMA Internal Medicine|February 26, 2014
Vegetarian diets and blood pressure: a meta-analysisYoko Yokoyama, Kunihiro Nishimura, Neal D Barnard, et al.Biochemical Pharmacology|October 1, 1985
Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agentN D Lalwani, M K Reddy, S Ghosh, et al.The Journal of Pediatrics|December 1, 1993
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraV S Blanchette, B Luke, M Andrew, et al.Pageof 32